Inhibition of glioblastoma malignancy by Lgl1.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4294391)

Published in Oncotarget on November 30, 2014

Authors

Alexander Gont1, Jennifer E L Hanson2, Sylvie J Lavictoire2, Manijeh Daneshmand3, Garth Nicholas4, John Woulfe5, Amin Kassam6, Vasco F Da Silva7, Ian A J Lorimer8

Author Affiliations

1: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
2: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada.
3: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
4: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
5: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada. Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
6: Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada. Aurora St. Luke's Medical Center, Aurora Health Care, Milwaukee, WI 53215, USA.
7: Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada.
8: Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada. Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Articles cited by this

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell (2011) 7.30

Transient expression of doublecortin during adult neurogenesis. J Comp Neurol (2003) 5.61

The PAR proteins: fundamental players in animal cell polarization. Dev Cell (2007) 4.92

Methods for cell and particle tracking. Methods Enzymol (2012) 4.80

Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45

Lgl, Pins and aPKC regulate neuroblast self-renewal versus differentiation. Nature (2005) 3.16

A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat Cell Biol (2003) 3.11

Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol (2004) 2.71

Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev (2004) 2.55

Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr Biol (2003) 2.38

Phosphorylation-induced autoinhibition regulates the cytoskeletal protein Lethal (2) giant larvae. Curr Biol (2005) 1.65

Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia (2011) 1.63

Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes. Dev Genes Evol (1998) 1.24

The genetic landscape of anaplastic astrocytoma. Oncotarget (2014) 1.09

Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts. Oncotarget (2013) 0.96

Adult neural stem cells: response to stroke injury and potential for therapeutic applications. Curr Stem Cell Res Ther (2011) 0.95

The tumor suppressor Lgl1 regulates NMII-A cellular distribution and focal adhesion morphology to optimize cell migration. Mol Biol Cell (2012) 0.94

PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. Oncotarget (2013) 0.91

Coordination of glioblastoma cell motility by PKCι. Mol Cancer (2010) 0.88

The tumor suppressor Lgl1 forms discrete complexes with NMII-A and Par6α-aPKCζ that are affected by Lgl1 phosphorylation. J Cell Sci (2013) 0.87

Loss of aPKCλ in differentiated neurons disrupts the polarity complex but does not induce obvious neuronal loss or disorientation in mouse brains. PLoS One (2013) 0.83

The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesis. Oncogene (2012) 0.82

Connecting epithelial polarity, proliferation and cancer in Drosophila: the many faces of lgl loss of function. Int J Dev Biol (2013) 0.78